Trademark Attorney / Law Firm
David F. Sawrie – Trademark Portfolio
David F. Sawrie specializes in Class 1 (Chemicals) trademark filings before the United States Patent and Trademark Office (USPTO), with 5 of 8 total filings concentrated in this category. The practice also covers Class 5 (Pharmaceuticals) along with 5 other Nice Classification classes. Filing activity spans from 2016 to 2025. Currently, 0 trademarks are registered and 3 are pending.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
David F. Sawrie's trademark practice covers 5 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademark applications has David F. Sawrie filed?
David F. Sawrie has filed 8 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 3 pending, 5 abandoned.
What trademark classes does David F. Sawrie specialize in?
David F. Sawrie has filed trademarks across 5 Nice Classification classes. The most common practice areas include Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 25 (Clothing), Class 42 (Computer & Scientific), Class 21 (Housewares). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
How long has David F. Sawrie been filing trademarks?
David F. Sawrie's trademark filing history with the USPTO spans from 2016 to 2025, covering 9 years of trademark practice. During this period, David F. Sawrie has handled 8 trademark applications.
What is David F. Sawrie's trademark registration success rate?
David F. Sawrie has a 0% trademark registration rate, with 0 out of 5 resolved applications resulting in successful registration. Currently, 3 applications are pending review.